D-PENICILLAMINE TREATMENT IMPROVES SURVIVAL IN PRIMARY BILIARY CIRRHOSIS
- 1 June 1981
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 317 (8233), 1275-1277
- https://doi.org/10.1016/s0140-6736(81)92456-9
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- PRIMARY BILIARY CIRRHOSIS IS A DRY GLAND SYNDROME WITH FEATURES OF CHRONIC GRAFT-VERSUS-HOST DISEASEThe Lancet, 1980
- Reduction of Immune Complexes and Immunoglobulins Induced by D-Penicillamine in Primary Biliary CirrhosisNew England Journal of Medicine, 1979
- Serum bilirubin: a prognostic factor in primary biliary cirrhosis.Gut, 1979
- D-penicillamine in primary biliary cirrhosis: Apparent beneficial effects in spite of a lack of correlation with changes in hepatic copper concentrationsGastroenterology, 1978
- Circulating Immune Complexes and Complement Activation in Primary Biliary CirrhosisNew England Journal of Medicine, 1978
- Effect of Penicillamine on the Proliferative Response of Human LymphocytesExperimental Biology and Medicine, 1978
- Lymphocyte populations in liver biopsy specimens from patients with chronic liver disease.Gut, 1977
- The Presentation and Diagnosis of 100 Patients with Primary Biliary CirrhosisNew England Journal of Medicine, 1973
- IMPAIRED DELAYED HYPERSENSITIVITY IN PRIMARY BILIARY CIRRHOSISThe Lancet, 1969
- LIVER-COPPER LEVELS IN LIVER DISEASEThe Lancet, 1968